Association Between Folate Metabolism Risk, Collateral Circulation, and Hemorrhagic Risk in Moyamoya Disease
- PMID: 39775251
- DOI: 10.1007/s12975-024-01324-y
Association Between Folate Metabolism Risk, Collateral Circulation, and Hemorrhagic Risk in Moyamoya Disease
Abstract
Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) polymorphisms are known risk factors for vascular diseases due to the impact on folate metabolism dysfunction and homocysteine (Hcy) accumulation. This study aimed to investigate the association between folate metabolism risk and hemorrhagic risk in moyamoya disease (MMD). In this prospective study, we enrolled 350 MMD patients with complete genotype data for MTHFR and MTRR. Patients were divided into non-hemorrhagic and hemorrhagic MMD groups. Folate metabolism risk was classified into three levels according to genotype configurations. We analyzed the association between folate metabolism risk and hemorrhagic risk in MMD. Furthermore, the association between folate metabolism risk, collateral circulation, and periventricular anastomosis (PA) was assessed. In vitro experiments were conducted on HBMECs to explore the potential mechanism. TT genotype and T allele in MTHFR C677T were significantly associated with a lower risk of hemorrhage, whereas AC genotype and C allele in MTHFR A1298C were significantly linked to a higher risk of hemorrhage. Patients with high folate metabolism risk exhibited a significantly decreased risk of hemorrhage compared to those with low folate metabolism risk. Further analyses demonstrated that high folate metabolism risk was significantly correlated with poor collateral circulation and PA dilation and elevated levels of Hcy. In vitro experiments showed that increased Hcy levels significantly inhibited the proliferation, migration, and tube formation of HBMECs. This study identified a significant negative correlation between folate metabolism risk and hemorrhagic risk in MMD. URL: http://www.chictr.org.cn . Unique identifier: ChiCTR2200061889.
Keywords: Collateral circulation; Folate metabolism; Hemorrhage; Homocysteine; Moyamoya disease.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical Approval: The Beijing Tiantan Hospital Ethics Committee has reviewed and approved this research (KY2022-051–02). Informed Consent: All patients have signed the informed consent to participate in this study. Conflict of Interest: The authors declare no competing interests.
Similar articles
-
Synergistic Effects of MTHFR, MTRR, and MTR Gene Variants on Serum Folate Levels and Cognitive Function in Chinese Preschoolers: A Cross-Sectional Study.Nutrients. 2025 Aug 18;17(16):2666. doi: 10.3390/nu17162666. Nutrients. 2025. PMID: 40871695 Free PMC article.
-
Meta Analysis of Methylenetetrahydrofolate Reductase (MTHFR) C677T polymorphism and its association with folate and colorectal cancer.BMC Cancer. 2025 Jan 29;25(1):169. doi: 10.1186/s12885-025-13546-w. BMC Cancer. 2025. PMID: 39875876 Free PMC article.
-
Interrelationships among MTHFR gene polymorphisms, MTRR gene polymorphisms, and HBV gene BCP 1762/1764 mutations with disease progression in Chronic hepatitis B virus infection patients.Nucleosides Nucleotides Nucleic Acids. 2025;44(8):697-715. doi: 10.1080/15257770.2024.2406223. Epub 2024 Sep 19. Nucleosides Nucleotides Nucleic Acids. 2025. PMID: 39297586
-
Assessing the association between the methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and blood folate concentrations: a systematic review and meta-analysis of trials and observational studies.Am J Clin Nutr. 2015 Jun;101(6):1286-94. doi: 10.3945/ajcn.114.099994. Epub 2015 Mar 18. Am J Clin Nutr. 2015. PMID: 25788000
-
Association of C677T and A1298C polymorphisms of the MTHFR gene with maternal risk for Down syndrome: A meta-analysis of case-control studies.Mutat Res Rev Mutat Res. 2023 Jul-Dec;792:108470. doi: 10.1016/j.mrrev.2023.108470. Epub 2023 Sep 9. Mutat Res Rev Mutat Res. 2023. PMID: 37689109
Cited by
-
Recent Advances in Genetics of Moyamoya Disease: Insights into the Different Pathogenic Pathways.Int J Mol Sci. 2025 May 29;26(11):5241. doi: 10.3390/ijms26115241. Int J Mol Sci. 2025. PMID: 40508049 Free PMC article. Review.
References
-
- Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Archives of neurology. 1969;20(3):288–99. https://doi.org/10.1001/archneur.1969.00480090076012 .
-
- Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056–66. https://doi.org/10.1016/s1474-4422(08)70240-0 . - DOI - PubMed
-
- Nakagawa Y, Abe H, Sawamura Y, Kamiyama H, Gotoh S, Kashiwaba T. Revascularization surgery for moyamoya disease. Neurol Res. 1988;10(1):32–9. https://doi.org/10.1080/01616412.1988.11739812 . - DOI - PubMed
-
- Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016;18(1):2–11. https://doi.org/10.5853/jos.2015.01627 . - DOI - PubMed - PMC
-
- Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, et al. Genetics and biomarkers of Moyamoya disease: significance of RNF213 as a susceptibility gene. J Stroke. 2014;16(2):65–72. https://doi.org/10.5853/jos.2014.16.2.65 . - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical